This page lists the SEC filings reported by RA Capital Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | SEQUENOM INC | 4,681,026 | 4.1% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | DYAX CORP | 7,072,436 | 7.2% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | Vanda Pharmaceuticals Inc. | 2,444,732 | 8.7% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | POZEN INC /NC | 2,946,944 | 9.8% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | DERMA SCIENCES, INC. | 1,055,648 | 10.0% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | ONCOGENEX PHARMACEUTICALS, INC. | 659,051 | 6.8% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | SYNAGEVA BIOPHARMA CORP | 0 | 0.0% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | TENGION INC | 1,060,070 | 4.4% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | CardioNet, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | ADVENTRX PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | Alexza Pharmaceuticals Inc. | 1,622,967 | 2.2% | EDGAR |
| SC 13G/A | 2012-02-14 | RA CAPITAL MANAGEMENT, LLC | ACADIA PHARMACEUTICALS INC | 5,269,999 | 10.0% | EDGAR |
| SC 13G | 2011-12-27 | RA CAPITAL MANAGEMENT, LLC | ENDOCYTE INC | 2,617,472 | 7.3% | EDGAR |
| SC 13G | 2011-12-09 | RA CAPITAL MANAGEMENT, LLC | POZEN INC /NC | 2,119,495 | 7.1% | EDGAR |
| SC 13G | 2011-12-09 | RA CAPITAL MANAGEMENT, LLC | SEQUENOM INC | 5,169,800 | 5.2% | EDGAR |
| SC 13G | 2011-12-09 | RA CAPITAL MANAGEMENT, LLC | DYAX CORP | 5,288,176 | 5.4% | EDGAR |
| SC 13G | 2011-10-06 | RA CAPITAL MANAGEMENT, LLC | GENTA INC DE/ | 42,934,982 | 10.0% | EDGAR |
| SC 13G | 2011-10-03 | RA CAPITAL MANAGEMENT, LLC | TRIMERIS INC | 1,559,106 | 7.0% | EDGAR |
| SC 13G | 2011-09-07 | RA CAPITAL MANAGEMENT, LLC | CardioNet, Inc. | 1,335,582 | 5.5% | EDGAR |
| SC 13G | 2011-08-12 | RA CAPITAL MANAGEMENT, LLC | VENTRUS BIOSCIENCES INC | 650,000 | 5.3% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.